Investigation of -Lactamase-producing Multidrug-resistant Pseudomonas aeruginosa Isolated from Non-Tertiary Care Hospitals in Korea |
Sohn, Eui-Suk
(Division of Antimicrobial Resistance, Center for Infectious Disease Research, National Institute of Health)
Yoo, Jeong-Sik (Division of Antimicrobial Resistance, Center for Infectious Disease Research, National Institute of Health) Lee, Jeom-Kyu (Division of Antimicrobial Resistance, Center for Infectious Disease Research, National Institute of Health) Lee, Kyeong-Min (Division of Antimicrobial Resistance, Center for Infectious Disease Research, National Institute of Health) Chung, Gyung-Tae (Division of Antimicrobial Resistance, Center for Infectious Disease Research, National Institute of Health) Shin, Eun-Shim (Division of Antimicrobial Resistance, Center for Infectious Disease Research, National Institute of Health) Han, Sun-Young (Division of Antimicrobial Resistance, Center for Infectious Disease Research, National Institute of Health) Lee, Sang-Hee (Department of Biological Sciences, School of Biotechnology and Environmental Engineering, Myongji University) Kim, Joon (Department of Laboratory of Biochemistry, School of Life Sciences and Biotechnology, Korea University) Lee, Yeong-Seon (Division of Antimicrobial Resistance, Center for Infectious Disease Research, National Institute of Health) |
1 | Lee, S. H., J. Y. Kim, G. S. Lee, S. H. Cheon, Y. J. An, S. H. Jeong, and K. J. Lee. 2002. Characterization of , an AmpC-type plasmid-mediated -lactamase gene in a Korean clinical isolate of Escherichia coli. J. Antimicrob. Chemother. 49: 269-273 DOI ScienceOn |
2 | Partridge, S. and R. M. Hall. 2003. In34, a complex In5 family class 1 integron containing orf513 and dfrA10. Antimicrob. Agents Chemother. 47: 342-349 DOI |
3 | Trick, W. E., C. M. Kioski, K. M. Howard, G. D. Cage, J. I. Tokars, B. M. Yen, and W. R. Jarvis. 2000. Outbreak of Pseudomonas aeruginosa ventriculitis among patients in a neurosurgical intensive care unit. Infect. Control Hosp. Epidemiol. 21: 204-208 DOI ScienceOn |
4 | Lee, S. H., J. Y. Kim, S. K. Lee, W. Jin, and K. J. Lee. 2000. Discriminatory detection of extended-spectrum -lactamases by restriction fragment length dimorphism-polymerase chain reaction. Lett. Appl. Microbiol. 31: 307-312 DOI ScienceOn |
5 | Obritsch, M. D., D. N. Fish, R. MacLaren, and R. Jung. 2004. National surveillance of antimicrobial resistance in Pseudomonas aeruginosa isolates obtained from intensive care unit patients from 1993 to 2002. Antimicrob. Agents Chemother. 48: 4606-4610 DOI ScienceOn |
6 | Sekiguchi, J. I., T. Asagi, T. Miyoshi-Akiyama, A. Kasai, Y. Mizuguchi, M. Araake, T. Fujino, H. Kikuchi, S. Sasaki, H. Watari, T. Kojima, H. Miki, K. Kanemitsu, H. Kunishima, Y. Kikuchi, M. Kaku, H. Yoshikura, T. Kuratsuji, and T. Kirikae. 2007. Outbreaks of multidrug-resistant Pseudomonas aeruginosa in community hospitals in Japan. J. Clin. Microbiol. 45: 979-989 DOI ScienceOn |
7 | Ferrara, A. M. 2006. Potentially multidrug-resistant nonfermentative Gram-negative pathogens causing nosocomial pneumonia. Int. J. Antimicrob. Agents 27: 183-195 DOI ScienceOn |
8 | Falagas, M. E., P. K. Koletsi, and I. A. Bliziotis. 2006. The diversity of definitions of multidrug-resistant (MDR) and pandrug-resistant (PDR) Acinetobacter baumannii and Pseudomonas aeruginosa. J. Med. Microbiol. 55: 1619-1629 DOI ScienceOn |
9 | Hsu, D. I., M. P. Okamoto, R. Murthy, and A. Wong-Beringer. 2005. Fluoroquinolone-resistant Pseudomonas aeruginosa: Risk factors for acquisition and impact on outcomes. J. Antimicrob. Chemother. 55: 535-541 DOI ScienceOn |
10 | Shin, H.-J., S.-K. Lee, J. J. Choi, S. Koh, J.-H. Lee, S.-J. Kim, and S. T. Kwon. 2005. Cloning, expression, and characterization of a family B-type DNA polymerase from the hyperthermophilic crenarchaeon Pyrobaculum arsenaticum and its application to PCR. J. Microbiol. Biotechnol. 15: 1359-1367 과학기술학회마을 |
11 | Lodise, T. P., C. D. Miller, J. Graves, J. P. Furuno, J. C. McGregor, B. Lomaestro, E. Graffunder, and L. A. McNutt. 2007. Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance. Antimicrob. Agents Chemother. 51: 417-422 DOI |
12 | Jeong, S. H., I. K. Bae, S. G. Sohn, K. O. Park, Y. J. An, K. H. Sung, S. J. Jang, M. J. Heo, K. S. Yang, and S. H. Lee. 2006. First detection of in clinical isolate multiresistant Acinetobacter baumannii from Korea J. Microbiol. Biotechnol. 16: 1377-1383 과학기술학회마을 |
13 | Lee, K., Y. Chong, H. B. Shin, Y. A. Kim, D. Young, and J. H. Yum. 2000. Modified Hodge and EDTA-disk synergy tests to screen metallo--lactamase-producing strains of Pseudomonas and Acinetobacter species. Clin. Microbiol. Infect. 7: 88-102 |
14 | Baddour, L. M., D. V. Hicks, M. M. Tayidi, S. K. Roberts, E. Walker, R. J. Smith, D. S. Sweitzer, J. A. Herrington, and B. G. Painter. 1995. Risk factor assessment for the acquisition of fluoroquinolone-resistant isolates of Pseudomonas aeruginosa in a community-based hospital. Microb. Drug Resist. 1: 219-222 DOI |
15 | Gales, A. C., R. N. Jones, J. Turnidge, R. Rennie, and R. Ramphal. 2001. Characterization of Pseudomonas aeruginosa isolates: Occurrence rates, antimicrobial susceptibility patterns, and molecular typing in the global SENTRY antimicrobial surveillance program, 1997-1999. Clin. Infect. Dis. 32: S146-S155 |
16 | Weldhagen, G. F., B. Kim, C.-H. Cho, and S. H. Lee. 2006. Definitive nomenclature of GES/IBC-type extended-spectrum -lactamases. J. Microbiol. Biotechnol. 16: 1837-1840 과학기술학회마을 |
17 | Leibovici, L., I. Shraga, M. Drucker, H. Konigsberger, Z. Samra, and S. D. Pitlik. 1998. The benefit of appropriate empirical antibiotic treatment in patients with bloodstream infection. J. Intern. Med. 244: 379-386 DOI ScienceOn |
18 | Vahaboglu, H., R. Ozturk, H. Akbal, S. Saribas, O. Tansel, and F. Coskunkan. 1998. Practical approach for detection and identification of OXA-10-derived ceftazidime hydrolyzing extended-spectrum beta-lactamases. J. Clin. Microbiol. 36: 827-829 |
19 | Cho, B. G., C. H. Kim, B. K. Lee, and S. H. Cho. 2005. Comparison of antibiotic resistance of blood culture strains and saprophytic isolates in the presence of biofilms, formed by the intercellular adhesion (ica) gene cluster in Staphylococcus epidermidis. J. Microbiol. Biotechnol. 15: 728-733 과학기술학회마을 |
20 | Chastre, J. and J. L. Trouillet. 2000. Problem pathogens (Pseudomonas aeruginosa and Acinetobacter). Semin. Respir. Infect. 15: 287-298 DOI ScienceOn |
21 | Clinical and Laboratory Standards Institute (CLSI). 2006. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically, Approved Standard M7-A6, 7th Ed. Clinical and Laboratory Standards Institute, Wayne, PA, U.S.A |
22 | Poirel, L., T. Naas, D. Nicolas, L. Collet, S. Bellais, J.-D. Cavallo, and P. Nordmann. 2000. Characterization of VIM- 2, a carbapenem-hydrolyzing metallo-beta-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44: 891-897 DOI |
23 | Kiska, D. L. and P. H. Gilligan. 1999. Pseudomonas, pp. 517-525. In P. R. Murray, E. J. Baron, M. A. Pfaller, F. C. Tenover, and R. H. Yolken (eds.), Manual of Clinical Microbiology, 7th Ed. American Society for Microbiology, Washington, DC, U.S.A |
24 | Lee, S., Y. J. Park, M. Kim, H. K. Lee, K. Han, C. S. Kang, and M. W. Kang. 2005. Prevalence of Ambler class A and D beta-lactamases among clinical isolates of Pseudomonas aeruginosa in Korea. J. Antimicrob. Chemother. 56: 122-127 DOI ScienceOn |
25 | Livermore, D. M. 2002. Multiple mechanisms of antimicrobial resistance in Pseudomonas aeruginosa. Our worst nightmare? Clin. Infect. Dis. 34: 634-640 DOI ScienceOn |
26 | Poirel, L., L. Cabanne, H. Vahaboglu, and P. Nordmann. 2005. Genetic environment and expression of the extendedspectrum -lactamase gene in Gram-negative bacteria. Antimicrob. Agents Chemother. 49: 1708-1713 DOI ScienceOn |